Company Event • 27 Mar 2026 12:00 • Upcoming
Add To Calendar
Company Event • 18 Nov 2025 00:00 • Latest
Company Event • 10 Nov 2025 22:30
Company Event • 06 Nov 2025 21:00
Company Event • 06 Aug 2025 20:00
Search or
𝛼SK
𝛼SKENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
438
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
morex